Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Regenxbio (RGNX) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to $142.2 million.

  • Regenxbio's Other Gross PP&E Adjustments rose 566.61% to $142.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.2 million, marking a year-over-year increase of 566.61%. This contributed to the annual value of $136.2 million for FY2024, which is 569.85% up from last year.
  • Latest data reveals that Regenxbio reported Other Gross PP&E Adjustments of $142.2 million as of Q3 2025, which was up 566.61% from $140.6 million recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Other Gross PP&E Adjustments ranged from a high of $142.2 million in Q3 2025 and a low of $51.3 million during Q1 2021
  • Its 5-year average for Other Gross PP&E Adjustments is $117.3 million, with a median of $126.2 million in 2023.
  • In the last 5 years, Regenxbio's Other Gross PP&E Adjustments surged by 528568.77% in 2021 and then surged by 505.09% in 2024.
  • Over the past 5 years, Regenxbio's Other Gross PP&E Adjustments (Quarter) stood at $99.7 million in 2021, then rose by 18.34% to $118.0 million in 2022, then grew by 9.21% to $128.8 million in 2023, then increased by 5.7% to $136.2 million in 2024, then rose by 4.46% to $142.2 million in 2025.
  • Its Other Gross PP&E Adjustments was $142.2 million in Q3 2025, compared to $140.6 million in Q2 2025 and $138.6 million in Q1 2025.